Ono Pharmaceutical Co., Ltd. (TYO:4528)
2,377.50
+37.00 (1.58%)
Jun 26, 2026, 3:30 PM JST
Ono Pharmaceutical Employees
Ono Pharmaceutical had 4,206 employees as of March 31, 2026. The number of employees decreased by 81 or -1.89% compared to the previous year.
Employees
4,206
Change (1Y)
-81
Growth (1Y)
-1.89%
Revenue / Employee
122.63M JPY
Profits / Employee
16.59M JPY
Market Cap
1,117.20B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Kyowa Kirin | 5,161 |
| Santen Pharmaceutical | 3,849 |
| Astellas Pharma | 13,643 |
| Daiichi Sankyo Company | 19,765 |
| Otsuka Holdings | 37,758 |
| Chugai Pharmaceutical | 5,104 |
| JCR Pharmaceuticals | 987 |
| Perseus Proteomics | 32 |
Ono Pharmaceutical News
- 26 days ago - Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting - Business Wire
- 7 weeks ago - Ono Pharmaceutical Quarterly report: Q4 2026 - Filings
- 7 weeks ago - Ono Pharmaceutical Slides: Q4 2026 - Filings
- 2 months ago - Ono Pharma Announces Upcoming Presentations at the ASCO 2026 Annual Meeting - Business Wire
- 3 months ago - Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan - Business Wire
- 3 months ago - Ono Pharmaceutical Slides: Investor presentation - Filings
- 4 months ago - Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology - Business Wire
- 4 months ago - Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL - Business Wire